Serum Institute of India seeks indemnity against liabilities: Sources

Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.

from IndiaTV India: Google News Feed

Get Breaking news, Live news, and latest news from India and around the world on, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News